Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.317ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.317ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.317NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.397ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.397ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.397ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.397NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.6.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.54ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.54ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.54NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DR.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DR.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DR.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-13753.9France
BF.7.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.27NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.26ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.26NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.27NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.5.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.5.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.5.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.59ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.59ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.59ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.59NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used